Can PSA density identify prostate cancer progression in men on imaging guided active surveillance?

被引：0
|
作者：
Petrides, N. [1 ]
Philippou, Y. [1 ]
Giganti, F. [1 ]
Coe, J. [1 ]
Abu, V. [1 ]
Emberton, M. [1 ]
Allen, C. [1 ]
Punwani, S. [1 ]
Moore, C. M. [1 ]
机构：
[1] Univ Coll Hosp, London, England
来源：
BJU INTERNATIONAL | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P30
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [41] Implementation of PSA-based active surveillance in prostate cancer
    Jalloh, Mohamed
    Cooperberg, Matthew R.
    BIOMARKERS IN MEDICINE, 2014, 8 (05) : 747 - 753
  • [42] GENOMIC PROSTATE SCORE PREDICTS PROGRESSION IN MEN ON ACTIVE SURVEILLANCE
    Kornberg, Zachary
    Cowan, Janet E.
    Masic, Selma
    Chan, June M.
    Cooperberg, Matthew R.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E140 - E140
  • [43] The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance
    Monfared, Sina
    Fleishman, Aaron
    Korets, Ruslan
    Chang, Peter
    Wagner, Andrew
    Bubley, Glenn
    Kaplan, Irving
    Olumi, Aria F.
    Gershman, Boris
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (11) : 783.e21 - 783.e30
  • [44] Prostate cancer recurrence: can PSA guide imaging?
    P. Mapelli
    V. Panebianco
    Maria Picchio
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1781 - 1783
  • [45] Prostate cancer recurrence: can PSA guide imaging?
    Mapelli, P.
    Panebianco, V.
    Picchio, Maria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (12) : 1781 - 1783
  • [46] Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
    Ullrich, T.
    Arsov, C.
    Quentin, M.
    Mones, F.
    Westphalen, A. C.
    Mally, D.
    Hiester, A.
    Albers, P.
    Antoch, G.
    Schimmoeller, L.
    EUROPEAN RADIOLOGY, 2020, 30 (11) : 6042 - 6051
  • [47] Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
    T. Ullrich
    C. Arsov
    M. Quentin
    F. Mones
    A. C. Westphalen
    D. Mally
    A. Hiester
    P. Albers
    G. Antoch
    L. Schimmöller
    European Radiology, 2020, 30 : 6042 - 6051
  • [48] Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance
    Francisco, Ignacio F. San
    Werner, Lillian
    Regan, Meredith M.
    Garnick, Marc B.
    Bubley, Glenn
    DeWolf, William C.
    JOURNAL OF UROLOGY, 2011, 185 (02): : 471 - 476
  • [49] Role of PSA density in diagnosis of prostate cancer in obese men
    Chiu, Peter Ka-Fung
    Teoh, Jeremy Yuen-Chun
    Chan, Samson Yun-Sang
    Chu, Peggy Sau-Kwan
    Man, Chi-Wai
    Hou, See-Ming
    Ng, Chi-Fai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (12) : 2251 - 2254
  • [50] Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
    Kacker, Ravi
    Hult, Mariam
    San Francisco, Ignacio F.
    Conners, William P.
    Rojas, Pablo A.
    Dewolf, William C.
    Morgentaler, Abraham
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (01) : 16 - 20
12345